CAD 0.29
(0.0%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2022 | -5.76 Million CAD | -43.38% |
2021 | -4.02 Million CAD | -2771.62% |
2020 | -140.05 Thousand CAD | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 Q3 | 82.54 Thousand CAD | 2010.66% |
2023 Q2 | 3911.00 CAD | 101.32% |
2023 Q1 | -295.6 Thousand CAD | 61.62% |
2022 Q4 | -770.2 Thousand CAD | 22.21% |
2022 Q3 | -990.14 Thousand CAD | 69.19% |
2022 Q2 | -3.21 Million CAD | -305.64% |
2022 Q1 | -792.34 Thousand CAD | -43.13% |
2022 FY | -5.76 Million CAD | -43.38% |
2021 Q1 | -38.21 Thousand CAD | -15.63% |
2021 FY | -4.02 Million CAD | -2771.62% |
2021 Q2 | -33.01 Thousand CAD | 13.59% |
2021 Q4 | -553.56 Thousand CAD | 83.2% |
2021 Q3 | -3.29 Million CAD | -9880.67% |
2020 FY | -140.05 Thousand CAD | 0.0% |
2020 Q4 | -33.04 Thousand CAD | 0.0% |
2020 Q2 | -33.06 Thousand CAD | 0.0% |
2019 Q4 | -33.24 Thousand CAD | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -5.01 Million CAD | -14.92% |
Asep Medical Holdings Inc | -7.72 Million CAD | 25.313% |
BetterLife Pharma Inc. | -3.24 Million CAD | -77.974% |
BioVaxys Technology Corp. | -2.4 Million CAD | -140.022% |
ChitogenX Inc. | -2.83 Million CAD | -103.773% |
Rapid Dose Therapeutics Corp. | -3.73 Million CAD | -54.242% |
Defence Therapeutics Inc. | -12.65 Million CAD | 54.434% |
Entheon Biomedical Corp. | -313.99 Thousand CAD | -1736.599% |
Gemina Laboratories Ltd. | -5.08 Million CAD | -13.388% |
Glow Lifetech Corp. | -1.64 Million CAD | -251.052% |
Lexston Life Sciences Corp. | -674.71 Thousand CAD | -754.694% |
Pharmala Biotech Holdings Inc. | -762.95 Thousand CAD | -655.852% |
Doseology Sciences Inc. | -377.63 Thousand CAD | -1427.084% |
MYND Life Sciences Inc. | -1.8 Million CAD | -218.998% |
Nova Mentis Life Science Corp. | -1.2 Million CAD | -379.645% |
PharmaTher Holdings Ltd. | -3.04 Million CAD | -89.442% |
PreveCeutical Medical Inc. | -963.12 Thousand CAD | -498.757% |